Mohamed Khairie Issa's Insider Trades & SAST Disclosures

Mohamed Khairie Issa's most recent trade in Incyte Corp. was a trade of 14,237 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.

Share

Note

This is a custom search result for pattern Mohamed Khairie Issa.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2026	14,237	14,237	-		-	Employee Stock Option (right to buy)
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Sale of securities on an exchange or to another person at price $ 109.07 per share.	06 Jan 2026	10,856	66,132 (0%)	0%	109.1	1,184,064	Common Stock
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.66 per share.	06 Jan 2026	8,264	76,988 (0%)	0%	106.7	881,438	Common Stock
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2025	21,923	21,923	-		-	Performance Shares
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2025	19,735	19,735	-		-	Employee Stock Option (right to buy)
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2025	8,769	85,252 (0%)	0%		0	Common Stock
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2025	27,812	76,483 (0%)	0%		0	Common Stock
Incyte	Mohamed Khairie Issa	EVP, Head of US Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2025	48,671	48,671 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades